Introduction
The timing of puberty varies greatly in the general population and is influenced by both environmental and genetic factors [1] [2] [3] [4] [5] . Evidence for genetic regulation of pubertal timing derives from onset being highly correlated within racial/ethnic population groups, within families, and between monozygotic compared with dizygotic twins. The combined data suggest that 50-80% of the variation in pubertal timing is determined by genetic factors [1] [2] [3] [4] [5] . There is also strong evidence for environmental and physiologic effects on the timing of puberty, as well as evidence supporting secular trends in the timing of puberty [1, [6] [7] [8] . Changing environmental and secular influences do not, however, negate the significant role that genetic background plays in regulating the variation of pubertal timing within a population at any particular point in history. Gene by environment interactions may also play an important role in regulating the timing of puberty.
Much progress has been made in identifying genetic causes of disorders of puberty, such as hypogonadotropic hypogonadism and Kallmann syndrome, but the specific genetic factors that regulate the variation in pubertal timing in the general population remain elusive. The identification of these genes is difficult because pubertal timing is a complex genetic trait, where a direct, often one-to-one relationship between genotype and phenotype does not exist [9] , likely due to multigenic influences and interactions between genetic variants and environmental exposures [10] .
Insights from single gene disorders
The study of hypogonadotropic hypogonadism and Kallmann syndrome has led to the identification of many genes that play critical roles in the development and regulation of the hypothalamic pituitary gonadal (HPG) axis [3, [11] [12] [13] . For example, this work has defined roles for the genes that lead to hypogonadotropic hypogonadism (GNRHR, GPR54, FGFR1, PROK2, PROKR2, FGF8); to X-linked (KAL1) and autosomal (FGFR1, PROK2, PROKR2, FGF8) forms of Kallmann syndrome; to obesity and hypogonadotropic hypogonadism (LEP, LEPR, and PC1); and to abnormal HPG development (DAX1, SF-1, HESX-1, LHX3, and PROP-1).
Genetic causes of other disorders of pubertal development, such as precocious puberty secondary to activating mutations of the leuteinizing hormone (LH) receptor or to activating mutations in the gene for the a-subunit of the stimulatory G protein in McCune-Albright syndrome, have also been described. The reader is referred to recent review articles for further discussion of these genes and disorders [11, 14] ; here, we focus on investigation of genes that may regulate pubertal timing at the hypothalamic level.
Normosmic hypogonadotropic hypogonadism
Hypogonadotropic hypogonadism with normal olfaction has been primarily associated with mutations in gonadotropin-releasing hormone receptor (GNRHR) as well as Gprotein coupled receptor 54 (GPR54), the G-protein coupled receptor for kisspeptins (the products of KISS-1) [15] [16] [17] [18] [19] [20] [21] [22] [23] . GNRHR was the first gene discovered to cause autosomal recessive hypogonadotropic hypogonadism [15, 24] . At least 20 mutations in GNRHR have been identified, the majority of which occur as compound heterozygotes. Several studies have attempted to quantify the frequency of GNRHR mutations in normosmic hypogonadotropic hypogonadism, with resulting estimates ranging from 3.5-10.4% [25, 26] . One report cited a case of constitutional delay of growth and puberty (CDGP) associated with a homozygous partial loss of function mutation in the GNRHR [27] and pedigrees of probands with hypogonadotropic hypogonadism can include individuals with delayed but otherwise normal puberty. However, more extensive analyses suggest that genetic variation in GNRH or GNRHR is not a common cause of late puberty in the general population [28, 29 ] .
Over the last 5 years, research into the KISS-1/GPR54 system has revealed that it is a critical component of the HPG axis and is necessary for pubertal onset, as demonstrated in both animal and human studies. The KISS-1/ GPR54 signaling complex was first described as an important regulator of the HPG axis in 2003 when two independent groups reported deletions and inactivating mutations of GPR54 in patients with hypogonadotropic hypogonadism [16, 18] . Conversely, an autosomal dominant GPR54 mutation, which leads to prolonged activation of kisspeptin-responsive intracellular signaling pathways, has been reported in a girl with idiopathic central precocious puberty [30 ] . Thus, it is clear that activation of GPR54 by kisspeptins plays a pivotal role in the onset of puberty. It is not yet known, however, whether the KISS-1/GPR54 system is the initial trigger of puberty or whether it acts as a downstream effector of other yet to be identified regulatory factors [31, 32 ].
Kallmann syndrome
Investigation of Kallmann syndrome (hypogonadotropic hypogonadism with anosmia/hyposmia) has led to the identification of several genes that are critical to HPG axis function and olfactory development. Loss of function mutations in Kallmann syndrome 1 (KAL-1) [33] [34] [35] and fibroblast growth factor receptor 1 (FGFR1) [36] are implicated in the X-linked and autosomal dominant forms of the disease, respectively. However, mutations in these two genes account for only approximately 20% of patients with Kallmann syndrome [37] . Recently, mutations in the prokineticin receptor-2 (PROKR2) and prokinetcin-2 (PROK2) genes were identified in a cohort of Kallmann syndrome patients [37] . These genes encode a G-protein coupled receptor (PROKR2) and its ligand (PROK2) and demonstrate that prokineticin signaling is important for olfactory and HPG axis development. One of the patients in this series was heterozygous for both a PROKR2 mutation and a KAL1 mutation, suggesting a possible digenic mode of inheritance [37] . Finally, mutations in nasal embryonic LHRH factor (NELF), which plays a role in migration of GnRH neurons and olfactory axon outgrowth [38] , have also been implicated in the pathogenesis of Kallmann syndrome [39] . A heterozygous deletion in NELF has been reported as a component, along with FGFR1, of digenic Kallmann syndrome, but it is not clear whether mutations in NELF alone lead to Kallmann syndrome [40 ] .
It is important to recognize that the distinction among the different abnormalities of pubertal development is not absolute. For example, mutations in FGFR1 can cause both Kallmann syndrome and normosmic hypogonadotropic hypogonadism [41] , and a homozygous mutation in PROK2 has been reported to cause both Kallmann syndrome and normosmic hypogonadotropic hypogonadism within a single kindred [42 ] . A more comprehensive study of PROK2 and PROKR2 in hypogonadotropic hypogonadism and Kallmann syndrome patients found mutations in both genes in anosmic and normosmic individuals [43 ] . Recently, mutations in FGF8, a ligand for FGFR1, were identified in hypogonadotropic hypogonadism patients with variable olfactory phenotypes [44 ] . It has also been reported that loss of function mutations in FGFR1 can cause delayed puberty in members of hypogonadotropic hypogonadism pedigrees [41, 45] . It remains possible that genetic variation in FGFR1 is a common cause of delayed puberty or CDGP in the general population, but recent extensive analysis of variants in FGFR1 found no substantial association with age at menarche [29 ] . Cases of reversible hypogonadotropic hypogonadism have also been reported [46 ] , further blurring the distinction between hypogonadotropic hypogonadism and CDGP. Finally, as mentioned earlier, further complexity derives from two groups' recent reports that hypogonadotropic hypogonadism can result from the combination of mutations in different genes (e.g. FGFR1 and NELF; FGFR1 and GNRHR; PROKR2 and KAL1) [37, 40 ] . These initial reports likely represent just the beginning of our understanding of the roles that multigenic inheritance and modifier genes play in the phenotypic variability within hypogonadotropic hypogonadism.
Leptin and other genes
Hypogonadotropic hypogonadism can also result from defects in the leptin (LEP) or the leptin receptor (LEPR) genes, highlighting the importance of nutrition in modulating the HPG axis. These findings initially led to speculation that leptin was a trigger for pubertal onset [47] ; however, the more widely held view is that leptin acts as a permissive factor in pubertal maturation [4] . Thus, it has been postulated that genetic variation in LEP or LEPR could play a role in regulating the timing of puberty; however, recent association studies have found no substantial association between common polymorphisms in LEP and LEPR and CDGP or age at menarche [29 ,48] .
Other causes of hypogonadotropic hypogonadism include mutations in genes that are critical to HPG development. This category includes the orphan nuclear receptors DAX1 (dosage-sensitive sex reversal adrenal congenital hypoplasia (DSS-AHC) critical region on the X chromosome) and steroidogenic factor-1 (SF-1). Mutations in several pituitary transcription factors, including HESX-1, LHX3, and PROP1, can lead to combined pituitary hormone deficiencies that include hypogonadotropic hypogonadism as a phenotype. Finally, prohormone convertase-1 (PC-1) has been associated with obesity and hypogonadotropic hypogonadism, possibly as a result of defective processing of neuropeptides or prohormones that are components of GnRH secretion [13, 49] .
Genetic variation in normal puberty
From the previous discussion, it is clear that the information gained from the study of hypogonadotropic hypogonadism and Kallmann syndrome is critical to our understanding of the reproductive-endocrine axis; however, the role that the genes (and pathways) identified in these disorders play in regulating variation in pubertal timing within the general population remains unclear. CDGP, which likely represents the extreme end of normal pubertal timing, clusters in families and has a strong genetic component [50,51 ,52 ,53-56] . Idiopathic central precocious puberty may also have a significant genetic component [57] , and one child with a mutation in GPR54 and precocious puberty has been reported [30 ] . Thus, less severe, more common genetic variation (polymorphisms) in any of the known hypogonadotropic hypogonadism or Kallmann syndrome genes (or others that have yet to be identified) could help explain the variation in pubertal timing seen within the general population. For several phenotypes, such as height and diabetes, SNPs in the same genes that cause monogenic forms of the disease or phenotype have been associated with the common, complex trait, and it is possible that this could be the case for puberty as well [58] [59] [60] [61] [62] . This paradigm is illustrated in Fig. 1 [63] , which depicts what is known and unknown about the overlap among the genetic causes of the different categories of delayed puberty. It reiterates that the genes that regulate timing of puberty in the general population or in populations with CDGP remain to be determined: the genes that play a role in determining why, for example, one young woman begins puberty at age 9 years and another at 12 years remain elusive.
We and others are actively investigating the role that sequence variation in genes responsible for hypogonadotropic hypogonadism and Kallmann syndrome (as well as other puberty-related genes) plays in modulating pubertal timing. The hypothesis is that common sequence variants (such as single nucleotide polymorphisms, SNPs, generally present in at least 5% of the population), each exerting a relatively small effect on the phenotype, act in combination to influence the timing of puberty. An alternative, although not mutually exclusive, hypothesis A paradigm for understanding the genetics of puberty is shown. Some genes underlying the pathogenesis of Kallmann syndrome and hypogonadotropic hypogonadism have been identified and are depicted with each diagnosis; less is known about the genetic basis of constitutional delay of growth and puberty. There is overlap between the three clinical entities as illustrated by the overlapping circles. There is also likely overlap in their genetic bases, as has been reported for FGFR1 (in Kallmann syndrome, hypogonadotropic hypogonadism, and constitutional delay of growth and puberty), GNRHR (in hypogonadotropic hypogonadism and possibly constitutional delay of growth and puberty), PROK2 (in Kallmann syndrome and hypogonadotropic hypogonadism), PROKR2 (in Kallmann syndrome and hypogonadotropic hypogonadism), and FGF8 (in Kallmann syndrome and hypogonadotropic hypogonadism). In both KS and HH, approximately 70% of the genetic causes are still unknown. Figure modified with permission [63] .
is that larger numbers of rare variants, each present in perhaps 1% or less of the population, exert modest-tolarge individual effects that explain much of the genetic variance in pubertal timing. One approach to addressing both of these mechanisms is resequencing of candidate genes to determine if sequence variants are present at different frequencies among individuals with early or late pubertal development. We have resequenced the exonic regions of several candidate genes, including GNRHR, GNRH, LEP, LEPR, and FGFR1, in populations of approximately 50 individuals with late, but otherwise normal pubertal development [28,29 ,48] . Thus far, no variants have been identified in these genes that explain the variation in pubertal timing within the general population. However, recent studies that used resequencing to identify variants that control triglyceride levels suggest that several hundred to thousands of individuals/DNA samples may be needed to employ this strategy most effectively [64 ,65] .
Another approach, which focuses on common variants, is to use association studies to investigate whether particular SNPs are associated with alterations in pubertal timing. Instead of resequencing, these studies usually involve genotyping a relatively small panel of SNPs and determining if the frequency of any of the SNPs associates with a particular phenotype. Some of these studies have reported promising results; for example, several independent reports have associated variants in cytochrome P450c17a (CYP17), which is involved in estrogen biosynthesis, with early menarche [66] [67] [68] [69] [70] [71] [72] .
On the other hand, conflicting reports have been published regarding the association between the age of menarche and other genes, including catechol-O-methyltransferase (COMT), which is important in estrogen metabolism [69, 73] , estrogen receptor a [69, [74] [75] [76] [77] , the sex-hormone binding globulin (SHBG) gene [78] , and the androgen receptor [79, 80] . Associations have also been reported between age at menarche and SNPs in the cytochrome P450 family 19 (CYP19) [81] and insulin-like growth factor 1 (IGF1) [82] genes, but these associations have not been replicated. We tested the reportedly associated SNPs in many of these genes for association with age at menarche in a population of 1800 women but found no evidence of replication of any of the reported associations [29 ] . Possible associations between genes involved in sex steroid metabolism and age at menarche are intriguing. However, it remains to be determined whether these effects will be verified and whether they modulate estrogen responsiveness or affect the maturation and central activation of the HPG axis, including the increased GnRH secretion that signifies the onset of central puberty.
To examine central regulation of the HPG axis more directly, we have used association studies to test for associations between common variants in ten hypogonadotropic hypogonadism-related genes (GNRH, GNRHR, GPR54, KISS1, LEP, LEPR, FGFR1, KAL1, PROK2, and PROKR2) and age at menarche. However, only nominally significant associations between SNPs in several of the genes and age at menarche were identified, indicating that genetic variation in these 10 genes does not appear to be a substantial modulator of pubertal timing in the general population [29 ] . Other work has also shown no evidence for substantial association between SNPs in GNRH, GNRHR [28] or LEP, LEPR [48] and alterations in pubertal timing. However, variation near these genes that lies outside the regions typically studied in candidate gene association studies could still influence population variation in the timing of puberty, as is the case for a common variant near MC4R and obesity [83 ] .
More likely, though, is that unless other genes, or combinations of genes, in these pathways modulate the timing of puberty in the general population, new regulators need to be identified and studied [31, 32 ] . The need to identify new genes and pathways is perhaps not surprising since mutations in known genes are only responsible for about 30% of the cases of hypogonadotropic hypogonadism and Kallmann syndrome [11, 40 ]. Indeed, most (although not all) of the genes that have recently been identified through genome-wide association studies as being associated with various complex traits have not been prior candidate genes for the phenotypes in question.
Population variation in pubertal timing
The timing of the appearance of the different secondary sexual characteristics that typify puberty varies among population groups and among individuals within a population [1]. For example, age at menarche is known to vary among different ethnic groups within the USA [84] [85] [86] [87] [88] [89] [90] . Given this, it seems reasonable to hypothesize that there is an association between global genetic ancestry and markers of pubertal timing. To test this hypothesis, we genotyped SNPs that show high variation in frequency in different population groups (ancestry informative markers) to estimate global genetic ancestry and used those estimates to test for an association between genetic ancestry and age at menarche within a multiethnic group of individuals. We found significant evidence of association between European ancestry and age at menarche among Latinas, with increased European ancestry and decreased Native American ancestry associated with late menarche, and suggestive evidence of association between Native Hawaiian ancestry and age at menarche in Native Hawaiians, with increased Native Hawaiian ancestry and decreased European and East Asian ancestry associated with early menarche (Fig. 2) . In JapaneseAmericans increased East Asian ancestry was associated with late menarche, although the difference in estimated ancestry between the early and late menarche groups was very slight, meaning that further investigation is necessary to determine whether this represents a real, relevant association. We did not see any association between estimated genetic ancestry and menarche in Whites or African-Americans [29 ] . It is important to note, however, that the effect of estimated global ancestry on age at menarche is small, so it likely does not fully explain the differences observed among racial/ ethnic groups.
Quantitative trait loci associated with timing of puberty One approach to discovering new genes that modulate pubertal timing is genome-wide linkage analyses, which are designed to identify regions of the genome [quantitative trait loci (QTLs)] that harbor genes that modulate a specific trait. Linkage studies do not require a-priori assumptions about causative genes or pathways and may lead to discovery of novel regulatory genes. Several recent studies have used linkage to investigate the genetic basis for variation in age at menarche (AAM) in human populations (see Table  1 ). Guo et al. [91] used a genome-wide linkage analysis of AAM in 2461 Caucasian women and identified a statistically significant linkage signal at 22q13 (LOD 3.70). Rothenbuhler et al. [92] investigated 98 sister pairs for AAM and for AAM adjusted for weight at time of menarche. The weight adjusted AAM genome scan revealed QTLs with strongly suggestive LOD scores at 16q21, 16q12, and 8p12. More recently, a much larger linkage study in 13 697 individuals and 4899 sister-pairs of European ancestry revealed only a suggestive LOD score on chromosome 12q [93 ] . Inspection of these and other studies in Table 1 reveals that none of the findings have been independently replicated and that each describes QTLs at different genomic locations. Thus, the results to date could represent false positives or false negatives and replication is needed before one can conclude that linkage analyses have identified areas of the genome that modulate AAM. In particular, the lack of a significant finding in the most recent large linkage study suggests that no single QTL explains a large proportion of the variance in AAM.
As a corollary to human studies, investigation using animal models may suggest new lines of investigation for human studies. A statistically significant QTL associated with timing of vaginal opening (a phenotypic marker of puberty in mice) has been identified and validated on mouse chromosome 6 in a region that corresponds to human chromosome 12p11-12 [94] . This and other studies [32 ,95] may eventually provide Mean ancestry estimates for each self-reported racial/ethnic group separated by early and late menarche. The 'major ethnicity' on the y-axis represents the estimated contribution of the ancestry that has the largest contribution to a given self-reported ethnic group. For African-Americans, major ethnicity is estimated West African ancestry; for Native Hawaiians, major ethnicity is estimated Native Hawaiian ancestry; for Japanese-Americans, major ethnicity is estimated East Asian ancestry; for Latinas, major ethnicity is estimated European ancestry; for Whites, major ethnicity is estimated European ancestry. , Early menarche; , late menarche. ÃÃÃ P < 0.01, ÃÃ P < 0.05, Ã P < 0.1. Figure reproduced with permission [29 ] .
important clues as to new candidate genes/pathways to investigate in humans.
Genome-wide association studies
Finally, great progress has recently been made using genome-wide association studies (GWAS) to identify genes that affect susceptibility to common diseases and other complex trait phenotypes, for example, obesity and height [83 ,96,97,98 ,99,100] . Unlike traditional association studies that use relatively small candidate gene-based SNP panels, GWAS test for association between a particular disease/phenotype and as many as 900 000 SNPs from throughout the genome. This technique is only just beginning to be used to examine the age of pubertal onset, but GWAS regarding age of menarche will be completed soon and results from these studies may help to identify important new regulatory genes and pathways.
Conclusion
There is great variation in the timing of puberty in humans. The exact causes and mechanisms underlying this variation are still largely unknown, but new attempts to use genetics and genomics may inform our understanding of the spectrum of pubertal development. Much progress has been made in identifying genes that underlie reproductive endocrine disorders such as hypogonadotropic hypogonadism and Kallmann syndrome. Less progress has been made in our understanding of the regulation of pubertal timing in the general population, but the necessary experimental methods are in place to facilitate the identification of these genes as well. If puberty is like other complex traits with proven associations, most findings will be novel, leading to the identification of new biology surrounding puberty in the general population.
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